Vaccinex Market Cap

Vaccinex has a market cap or net worth of $2.44 million as of April 29, 2026. Its market cap has decreased by -14.15% in one year.

Market Cap

2.44M

Enterprise Value

3.02M

Revenue

601.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.91

Market Cap Chart

Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 2.44M, a decrease of -98.13%. That is a compound annual growth rate of -40.29%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	2.41M	-16.32%
Dec 31, 2025	2.88M	9.74%
Dec 31, 2024	2.62M	-68.42%
Dec 29, 2023	8.31M	-74.16%
Dec 30, 2022	32.15M	0.35%
Dec 31, 2021	32.03M	-30.87%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CASI Pharmaceuticals	2.71M
VitaSpring Biomedical	2.30M
Oncology Pharma	3.48M
AXIM Biotechnologies	2.22M
ProtoKinetix	2.21M
Avenue Therapeutics	2.17M
Bioxytran	3.97M
Nymox Pharmaceutical	4.08M

Market Cap Rankings